Attract talent




ViaCyte is a regenerative medicine company focused on the discovery, development & commercialization of novel cell replacement therapies to treat diabetes.


Add photos to showcase ViaCyte’s culture


Add ViaCyte’s values

Insider experiences

Share your experience of working at ViaCyte

Michael Yang
CEO, President
Howard Foyt
Chief Medical Officer
Steve White
Chief Technology Officer
Liz Bui
VP, Intellectual Property and Counsel & Diversity & Inclusion Officer
Manasi Sinha Jaiman
VP, Clinical Development
Steve Kradjian
VP, Regulatory and Quality
Anne Sandan
Vice President, Finance

Add your teams to show how people work together at ViaCyte

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.